These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 8395017

  • 1. Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene.
    MacDonald PN, Dowd DR, Nakajima S, Galligan MA, Reeder MC, Haussler CA, Ozato K, Haussler MR.
    Mol Cell Biol; 1993 Sep; 13(9):5907-17. PubMed ID: 8395017
    [Abstract] [Full Text] [Related]

  • 2. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
    Haussler MR, Jurutka PW, Hsieh JC, Thompson PD, Selznick SH, Haussler CA, Whitfield GK.
    Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
    [Abstract] [Full Text] [Related]

  • 3. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M, Freedman LP, Li H, Christakos S.
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [Abstract] [Full Text] [Related]

  • 4. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A, Van Wijnen AJ, Desai RK, Pols HA, Birkenhäger JC, Deluca HF, Denhardt DT, Stein JL, Van Leeuwen JP, Stein GS, Lian JB.
    Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
    [Abstract] [Full Text] [Related]

  • 5. Heterodimeric DNA binding by the vitamin D receptor and retinoid X receptors is enhanced by 1,25-dihydroxyvitamin D3 and inhibited by 9-cis-retinoic acid. Evidence for allosteric receptor interactions.
    Thompson PD, Jurutka PW, Haussler CA, Whitfield GK, Haussler MR.
    J Biol Chem; 1998 Apr 03; 273(14):8483-91. PubMed ID: 9525962
    [Abstract] [Full Text] [Related]

  • 6. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK.
    J Endocrinol; 1997 Sep 03; 154 Suppl():S57-73. PubMed ID: 9379138
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H, Kurian SM, Hendy GN, White J, deLuca HF, Evans CO, Nanes MS.
    Endocrinology; 1994 Jun 03; 134(6):2524-31. PubMed ID: 8194478
    [Abstract] [Full Text] [Related]

  • 8. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
    Imai Y, Pike JW, Koeffler HP.
    Leuk Res; 1995 Mar 03; 19(3):147-58. PubMed ID: 7700077
    [Abstract] [Full Text] [Related]

  • 9. Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression.
    Sasaki H, Harada H, Handa Y, Morino H, Suzawa M, Shimpo E, Katsumata T, Masuhiro Y, Matsuda K, Ebihara K.
    Biochemistry; 1995 Jan 10; 34(1):370-7. PubMed ID: 7819220
    [Abstract] [Full Text] [Related]

  • 10. Isolation of baculovirus-expressed human vitamin D receptor: DNA responsive element interactions and phosphorylation of the purified receptor.
    Jurutka PW, MacDonald PN, Nakajima S, Hsieh JC, Thompson PD, Whitfield GK, Galligan MA, Haussler CA, Haussler MR.
    J Cell Biochem; 2002 Jan 10; 85(2):435-57. PubMed ID: 11948698
    [Abstract] [Full Text] [Related]

  • 11. Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptors.
    Fernandez-Martin JL, Kurian S, Farmer P, Nanes MS.
    Mol Cell Endocrinol; 1998 Jun 25; 141(1-2):65-72. PubMed ID: 9723887
    [Abstract] [Full Text] [Related]

  • 12. Regulation of renal parathyroid hormone receptor expression by 1, 25-dihydroxyvitamin D3 and retinoic acid.
    Sneddon WB, Barry EL, Coutermarsh BA, Gesek FA, Liu F, Friedman PA.
    Cell Physiol Biochem; 1998 Jun 25; 8(5):261-77. PubMed ID: 9792954
    [Abstract] [Full Text] [Related]

  • 13. Salt concentration determines 1,25-dihydroxyvitamin D3 dependency of vitamin D receptor-retinoid X receptor--vitamin D-responsive element complex formation.
    Kimmel-Jehan C, Jehan F, DeLuca HF.
    Arch Biochem Biophys; 1997 May 01; 341(1):75-80. PubMed ID: 9143355
    [Abstract] [Full Text] [Related]

  • 14. Interaction between retinoic acid and vitamin D signaling pathways.
    Schräder M, Bendik I, Becker-André M, Carlberg C.
    J Biol Chem; 1993 Aug 25; 268(24):17830-6. PubMed ID: 8394351
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
    Pathrose P, Barmina O, Chang CY, McDonnell DP, Shevde NK, Pike JW.
    J Bone Miner Res; 2002 Dec 25; 17(12):2196-205. PubMed ID: 12469913
    [Abstract] [Full Text] [Related]

  • 16. Highly potent transcriptional activation by 16-ene derivatives of 1,25-dihydroxyvitamin D3. Lack of modulation by 9-cis-retinoic acid of response to 1,25-dihydroxyvitamin D3 or its derivatives.
    Ferrara J, McCuaig K, Hendy GN, Uskokovic M, White JH.
    J Biol Chem; 1994 Jan 28; 269(4):2971-81. PubMed ID: 8300629
    [Abstract] [Full Text] [Related]

  • 17. The retinoid X receptor agonist 9-cis-retinoic acid and the 24-hydroxylase inhibitor ketoconazole increase activity of 1,25-dihydroxyvitamin D3 in human skin in vivo.
    Kang S, Li XY, Duell EA, Voorhees JJ.
    J Invest Dermatol; 1997 Apr 28; 108(4):513-8. PubMed ID: 9077483
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of the 1,25-dihydroxyvitamin D3-induced increase in vitamin D receptor (VDR) levels and binding of VDR-retinoid X receptor (RXR) to a direct repeat (DR)-3 type response element by an RXR-specific ligand in human keratinocyte cultures.
    Jensen TJ, Henriksen LO, Sølvsten H, Kragballe K.
    Biochem Pharmacol; 1998 Mar 15; 55(6):767-73. PubMed ID: 9586948
    [Abstract] [Full Text] [Related]

  • 19. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L, Verstuyf A, Quack M, Van Camp M, Van Etten E, De Clercq P, Vandewalle M, Carlberg C, Bouillon R.
    J Bone Miner Res; 2001 Apr 15; 16(4):625-38. PubMed ID: 11315990
    [Abstract] [Full Text] [Related]

  • 20. Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid.
    Kane KF, Langman MJ, Williams GR.
    Cancer Res; 1996 Feb 01; 56(3):623-32. PubMed ID: 8564982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.